Los Alamos National Laboratory
HomeHome

SoftwareSoftware
       Attila ®
          Productivity
          Solutions
          Base Environment
       Acuros™

ApplicationsApplications
       Radiological Safety
       Medical Imaging
       Radiotherapy
       Fuel Transport/Storage
       Fusion Research
       Nuclear Power
          Pressure Vessel Fluence
          Reactor Analysis
       Homeland Security
       Shielding Design
       Oil Exploration

ServicesServices

PublicationsPublications
       Publications
       Benchmarks

CompanyCompany
       Company Mission
       Core Team
       Technical Advisors
       News/Events

SupportSupport

ContactContact
       Contact Us
       Employment

test
Nuclear Power
Pressure Vessel Fluence

Reactor Analysis
Applications
Join an Online Meeting
if you have been invited to participate in a web-based meeting, OR
to schedule an online presentation.
Contact Us
You are here >   Applications > Nuclear Power > Pressure Vessel Fluence
Register  |  
Enter Title Minimize
Attila® – Pressure Vessel Fluence 
 
Venus-2 Geometry.
 
Detailed Venus-2 geometry created in CAD within hours. Easily verified. Directly imported into Attila.
  
Features and Benefits
    Highly efficient in 3-D, no need for 2-D approximations
    Conformal modeling of geometry, no stair stepping
    Directly compatible with proven cross section libraries
    Automatic interpolation of source distributions to arbitrary mesh topology
    Solution obtained everywhere
    Visual, insightful post processing
    Easy to set-up, easy to verify
    Accurate, state-of-the-art solution methods
   
     
Computational mesh of 110,000 elements created within minutes.
 
Computational mesh of 110,000 elements created within minutes
  
Analysis performed within 35 minutes on a single 2.4 GHz AMD Opteron processor.
 
Analysis performed within 35 minutes on a single 2.4 GHz AMD Opteron processor. Results published in Nuclear Science NEA/NSC/DOC(2005)22, Venus-2 MOX-fuelled Reactor Dosimetry Calculations. Over 90% of Attila data points within 5% of experiment.
 
Print  

Acuros and Attila have not obtained marketing clearance by the US Food and Drug Administration
Copyright 2004 - 2009 by Transpire Inc. - All Rights Reserved
 
Hosted by: NetProCity